Reply to Lapenna

Affiliations

Comment

Julio C Alencar et al. Clin Infect Dis. 2021.

. 2021 Dec 16;73(12):2371.

doi: 10.1093/cid/ciab056.

No abstract available

Comment on

Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19).
de Alencar JCG, Moreira CL, Müller AD, Chaves CE, Fukuhara MA, da Silva EA, Miyamoto MFS, Pinto VB, Bueno CG, Lazar Neto F, Gomez Gomez LM, Menezes MCS, Marchini JFM, Marino LO, Brandão Neto RA, Souza HP; COVID Register Group. de Alencar JCG, et al. Clin Infect Dis. 2021 Jun 1;72(11):e736-e741. doi: 10.1093/cid/ciaa1443. Clin Infect Dis. 2021. PMID: 32964918 Free PMC article. Clinical Trial.
Antioxidant Therapy in Coronavirus Disease 2019: The Crucial Role of Early Treatment and Antioxidant Typology.
Lapenna D. Lapenna D. Clin Infect Dis. 2021 Dec 16;73(12):2370-2371. doi: 10.1093/cid/ciab055. Clin Infect Dis. 2021. PMID: 33503229 Free PMC article. No abstract available.

1. de Alencar JCG, Moreira C de L, Müller AD, et al. Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19. Clin Infect Dis Off Publ Infect Dis Soc Am 2020. doi: 10.1093/cid/ciaa1443. - DOI - PMC - PubMed
1. Richardson S, Hirsch JS, Narasimhan M, et al. ; the Northwell COVID-19 Research Consortium . Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 2020; 323:2052–9. - PMC - PubMed
1. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137:856–64, 864.e1. - PMC - PubMed
1. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142:37–46. - PubMed